Skip to main content
OpenTrials

Clinical trial condition

Homologous Recombination Deficiency

Explore clinical trials studying Homologous Recombination Deficiency. Study availability and eligibility vary by location and protocol.

10 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Homologous Recombination Deficiency trial results

Recruiting

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

NCT06545942

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Cancer, +36 more
Locations
  • Investigative Site #108 Goodyear, Arizona, United States
  • Investigative Site #101 La Jolla, California, United States
  • Investigative Site #111 San Francisco, California, United States
  • Investigative Site #104 Lake Mary, Florida, United States
View all 18 locations
View Trial Details
Recruiting

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

NCT04503265

Conditions
Adnexal Diseases, Advanced Malignant Neoplasm, Breast Cancer, +35 more
Locations
  • University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)

NCT04174716

Conditions
Homologous Recombination Deficiency, Homologous Recombination Repair Gene Mutation, Solid Tumors
Locations
  • National Cancer Centre Goyang, Gyeongggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Ajou University Hospital Suwon, Gyeonggi-do, South Korea
  • Gyeongsang National University Hospital Jinju, Gyeongsangnam-do, South Korea
View all 19 locations
View Trial Details

Related conditions